WO2004052916A3 - Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids - Google Patents

Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids Download PDF

Info

Publication number
WO2004052916A3
WO2004052916A3 PCT/US2003/038837 US0338837W WO2004052916A3 WO 2004052916 A3 WO2004052916 A3 WO 2004052916A3 US 0338837 W US0338837 W US 0338837W WO 2004052916 A3 WO2004052916 A3 WO 2004052916A3
Authority
WO
WIPO (PCT)
Prior art keywords
cis
cyclic peptides
novel cyclic
aminocycloalkanecarboxylic
acids
Prior art date
Application number
PCT/US2003/038837
Other languages
French (fr)
Other versions
WO2004052916A2 (en
Inventor
Guillan Juan R Granja
Original Assignee
Adaptive Therapeutics Inc
Guillan Juan R Granja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adaptive Therapeutics Inc, Guillan Juan R Granja filed Critical Adaptive Therapeutics Inc
Priority to AU2003302239A priority Critical patent/AU2003302239A1/en
Publication of WO2004052916A2 publication Critical patent/WO2004052916A2/en
Publication of WO2004052916A3 publication Critical patent/WO2004052916A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to cyclic peptides comprised of at least one cis-3-aminocycloalkanecarboxylic acid ('Ϝ-Acc').
PCT/US2003/038837 2002-12-06 2003-12-05 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids WO2004052916A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003302239A AU2003302239A1 (en) 2002-12-06 2003-12-05 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US43128302P 2002-12-06 2002-12-06
US60/431,283 2002-12-06
US45943603P 2003-03-31 2003-03-31
US60/459,436 2003-03-31
US47762203P 2003-06-10 2003-06-10
US60/477,622 2003-06-10

Publications (2)

Publication Number Publication Date
WO2004052916A2 WO2004052916A2 (en) 2004-06-24
WO2004052916A3 true WO2004052916A3 (en) 2004-09-16

Family

ID=32512326

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/038837 WO2004052916A2 (en) 2002-12-06 2003-12-05 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids

Country Status (2)

Country Link
AU (1) AU2003302239A1 (en)
WO (1) WO2004052916A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566765B2 (en) 2000-03-06 2009-07-28 Rigel Pharmaceuticals, Inc. Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
EP2074134A1 (en) * 2006-10-05 2009-07-01 Lonza Ag Method for peptide synthesis
US20160031962A1 (en) * 2012-04-20 2016-02-04 Kleomenis K. Barlos Solid phase peptide synthesis of insulin using side chain achored lysine
WO2015123433A2 (en) * 2014-02-12 2015-08-20 Goddard Labs, Inc. Rapid detection of human pathogens in plant material or water
BR122021009864B1 (en) * 2014-12-30 2022-08-30 Dow Agrosciences Llc COMPOSITION AND METHOD FOR CONTROL AND PREVENTION OF FUNGAL ATTACK IN A PLANT

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
US20010018422A1 (en) * 1998-07-08 2001-08-30 Basf Aktiengesellschaft Dolastatin 15 derivatives

Also Published As

Publication number Publication date
WO2004052916A2 (en) 2004-06-24
AU2003302239A1 (en) 2004-06-30
AU2003302239A8 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
WO2001034646A3 (en) Recombinant gelatins
WO2001064920A3 (en) Hybrid expression of neisserial proteins
WO2003052118A3 (en) Bgl4 beta-glucosidase and nucleic acids encoding the same
WO2002032383A3 (en) Novel use of short-chained carboxylic acids
DE60211535D1 (en) PROCESS FOR THE PREPARATION OF 2,5-DIFORMYLFURAN FROM CARBOHYDRATES
WO2004007664A3 (en) Nucleic acid vectors
WO2003074546A3 (en) Streptavidin-binding peptide
WO2002101003A3 (en) Stereoselective preparation of cyclic l-amino acids
WO2002083634A3 (en) Process for the preparation of cefpodoxime acid
WO2004052916A3 (en) Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids
IL157709A0 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
EP1568704A4 (en) Novel 2' ,5' -oligoadenylic acid analogues
EP1262536A3 (en) Fluorescent group-containing carbodiimide compound and process for producing the compound
WO2003007872A3 (en) Process for the preparation of citalopram hydrobromide
WO2003007937A1 (en) Antitumor agent containing cyclic polylactic acid
EG23429A (en) Novel a-oxygenated or a-thiolated carboxylic acid phenethylamide derivatives.
WO2003018795A1 (en) Novel rfrp-3 and dna thereof
WO2003031584A3 (en) Axon repair
WO2002083727A3 (en) Nucleic acid sequences of hyperplasies and tumors of the thyroid
AU2002363277A1 (en) Sequences for the preparation of 5-ketogluconic acid from gluconic acid
IL144063A0 (en) Process for the preparation of 1,1-cyclohexanediacetic acid
WO2004028447A3 (en) Novel compositions and methods for the treatment of psoriasis
AU2002366040A1 (en) Novel tetronic acid derivative
WO2004022657A3 (en) Increasing of the resorption of substances via skin and mucous membranes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTIFICATION OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO FORM 1205A SENT ON 14.12.05)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP